Additionally, it is worth considering that the levels of IL-6 and CRP in HCC may be influenced by various factors, such as the deterioration of liver function, the progression of HCC staging, and the immunophenotype of HCC. This evidence concerns the gene CRP and hepatocellular carcinoma.